A detailed history of Aigen Investment Management, LP transactions in Pfizer Inc stock. As of the latest transaction made, Aigen Investment Management, LP holds 37,549 shares of PFE stock, worth $1 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
37,549
Holding current value
$1 Million
% of portfolio
0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$27.7 - $31.39 $1.04 Million - $1.18 Million
37,549 New
37,549 $1.09 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $1.66 Million - $1.91 Million
64,192 Added 213.2%
94,301 $2.62 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $786,748 - $1.02 Million
30,109 New
30,109 $866,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $14.1 Million - $18.4 Million
357,896 New
357,896 $14.6 Million
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $2.22 Million - $2.64 Million
47,789 New
47,789 $2.51 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $4.8 Million - $5.95 Million
-104,900 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $4.33 Million - $6.43 Million
104,900 New
104,900 $6.03 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $8.52 Million - $10.9 Million
-217,104 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $7.8 Million - $8.83 Million
217,104 New
217,104 $8.5 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $2.83 Million - $3.59 Million
-84,437 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $530,606 - $622,522
-16,712 Reduced 16.52%
84,437 $3.1 Million
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $2.69 Million - $3.27 Million
89,368 Added 758.58%
101,149 $3.31 Million
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $318,440 - $454,982
11,781 New
11,781 $385,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.